Cardiovascular Disease (CVD) Completed Phase 3 Trials for Medroxyprogesterone acetate (DB00603)

Also known as: Cardio Vascular Disease / Cardiovascular Diseases / Cardio-vascular Disease / Cardiovascular Disease / Cardio-vascular Diseases / Diseases, Cardiovascular / Cardiovascular disease, unspecified / Heart diseases / Cardiovascular disorder / Cardiovascular disorder NOS / Disorder cardiovascular (NOS) / Cardiovascular disorder (NOS)

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000559Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)Prevention
NCT00000466Postmenopausal Estrogen/Progestin Interventions (PEPI)Prevention
NCT00000605Estrogen and Graft Atherosclerosis Research Trial (EAGER)Prevention